Stockscreener 앱 받기
3.59
4.77%
-0.18
시간 외 거래:
3.58
-0.010
-0.28%
전일 마감가:
$3.77
열려 있는:
$3.74
하루 거래량:
220.65K
Relative Volume:
0.12
시가총액:
$87.69M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-24.10%
1개월 성능:
+21.69%
6개월 성능:
+47.13%
1년 성능:
-67.92%
1일 변동 폭
$3.56
$4.00
1주일 범위
$3.56
$4.8395
52주 변동 폭
$1.47
$15.49
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
3.59 | 92.09M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
What risks investors should watch in Artiva Biotherapeutics Inc. stockMarket Performance Report & Daily Entry Point Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosInflation Watch & Weekly Stock Breakout Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Artiva Biotherapeutics Inc. stock daily chart insightsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - The Manila Times
Artiva Biotherapeutics to Host Webcast on Initial Safety and Translational Data for AlloNK in Autoimmune Disease Treatment - Quiver Quantitative
Can Artiva Biotherapeutics Inc. stock resist sector downturnsPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Relative strength of Artiva Biotherapeutics Inc. in sector analysis2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Advanced analytics toolkit walkthrough for Artiva Biotherapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025Quarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock is popular among millennialsWeekly Market Summary & AI Enhanced Trading Signals - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-03 03:05:55 - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Identifying reversal signals in Artiva Biotherapeutics Inc.July 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Oil Prices & Fast Entry and Exit Trade Plans - newser.com
Artiva Biotherapeutics Inc. stock volume spike explained2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 01:36:46 - newser.com
Published on: 2025-11-01 12:39:19 - newser.com
Published on: 2025-11-01 06:37:19 - newser.com
Best Small Cap Stocks To ConsiderOctober 19th - MarketBeat
Artiva Biotherapeutics (NASDAQ:ARTV) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockBull Run & Free Weekly Watchlist of Top Performers - newser.com
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewswire
Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease - San Diego Business Journal
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):